Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

An international study on activated partial thromboplastin time prolongation. Part 1 : Analytical results

Bauça, Josep Miquel ; Ajzner, Éva LU ; Cadamuro, Janne ; Hillarp, Andreas LU ; Kristoffersen, Ann Helen and Meijer, Piet (2022) In Clinica Chimica Acta 535. p.167-173
Abstract

Background: Unexpected prolongation of first-line coagulation tests, including activated partial thromboplastin time (APTT), should trigger further work-up by performing mixing tests to elucidate the underlying cause, direct further specific testing and clarify their possible clinical impact. The aim of our study was to assess whether methodological diversity has any impact on the APTT mixing test results and their interpretation. Material and methods: Two lyophilized plasma samples (case 1: heparin contamination [0.5 IU/mL]; case 2: factor VIII deficiency [0.13 IU/mL]) and their respective fictional clinical cases were sent to European laboratories for APTT measurement and performance of mixing tests. Participants were surveyed about... (More)

Background: Unexpected prolongation of first-line coagulation tests, including activated partial thromboplastin time (APTT), should trigger further work-up by performing mixing tests to elucidate the underlying cause, direct further specific testing and clarify their possible clinical impact. The aim of our study was to assess whether methodological diversity has any impact on the APTT mixing test results and their interpretation. Material and methods: Two lyophilized plasma samples (case 1: heparin contamination [0.5 IU/mL]; case 2: factor VIII deficiency [0.13 IU/mL]) and their respective fictional clinical cases were sent to European laboratories for APTT measurement and performance of mixing tests. Participants were surveyed about the methodology (reagents, analytical platform, reference ranges), APTT results, mixing test conditions, their classification (normal, equivocal, prolonged) and categorization of the sample (factor deficiency, presence of inhibitor, anticoagulant, unknown). Results: A total of 269 responses were included. For case 1, all participants reported a prolonged APTT, and 91% obtained no correction in the mixing test, without differences among reagents or analytical platforms. Only 15% of them selected the presence of an anticoagulant as the single cause for the prolongation. For case 2, 99% of participants reported a prolonged APTT, while some heterogeneity in the mixing test results was found. Eighty-six percent of participants selected factor deficiency as the cause for APTT prolongation. Conclusions: Most European laboratories obtained valid results for APTT and the subsequent mixing tests, despite using different methodologies. However, their classification could be improved. Therefore, more training and periodic evaluations are recommended to harmonize protocols and ensure proper result classification and categorization.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Activated partial thromboplastin time, APTT reagents, Coagulation tests, Laboratory diagnosis, Mixing test
in
Clinica Chimica Acta
volume
535
pages
167 - 173
publisher
Elsevier
external identifiers
  • scopus:85137068095
  • pmid:36041550
ISSN
0009-8981
DOI
10.1016/j.cca.2022.08.024
language
English
LU publication?
no
additional info
Publisher Copyright: © 2022
id
a955c888-3cce-4102-a25d-1717d62efae6
date added to LUP
2024-12-06 10:26:06
date last changed
2025-06-07 01:20:07
@article{a955c888-3cce-4102-a25d-1717d62efae6,
  abstract     = {{<p>Background: Unexpected prolongation of first-line coagulation tests, including activated partial thromboplastin time (APTT), should trigger further work-up by performing mixing tests to elucidate the underlying cause, direct further specific testing and clarify their possible clinical impact. The aim of our study was to assess whether methodological diversity has any impact on the APTT mixing test results and their interpretation. Material and methods: Two lyophilized plasma samples (case 1: heparin contamination [0.5 IU/mL]; case 2: factor VIII deficiency [0.13 IU/mL]) and their respective fictional clinical cases were sent to European laboratories for APTT measurement and performance of mixing tests. Participants were surveyed about the methodology (reagents, analytical platform, reference ranges), APTT results, mixing test conditions, their classification (normal, equivocal, prolonged) and categorization of the sample (factor deficiency, presence of inhibitor, anticoagulant, unknown). Results: A total of 269 responses were included. For case 1, all participants reported a prolonged APTT, and 91% obtained no correction in the mixing test, without differences among reagents or analytical platforms. Only 15% of them selected the presence of an anticoagulant as the single cause for the prolongation. For case 2, 99% of participants reported a prolonged APTT, while some heterogeneity in the mixing test results was found. Eighty-six percent of participants selected factor deficiency as the cause for APTT prolongation. Conclusions: Most European laboratories obtained valid results for APTT and the subsequent mixing tests, despite using different methodologies. However, their classification could be improved. Therefore, more training and periodic evaluations are recommended to harmonize protocols and ensure proper result classification and categorization.</p>}},
  author       = {{Bauça, Josep Miquel and Ajzner, Éva and Cadamuro, Janne and Hillarp, Andreas and Kristoffersen, Ann Helen and Meijer, Piet}},
  issn         = {{0009-8981}},
  keywords     = {{Activated partial thromboplastin time; APTT reagents; Coagulation tests; Laboratory diagnosis; Mixing test}},
  language     = {{eng}},
  month        = {{10}},
  pages        = {{167--173}},
  publisher    = {{Elsevier}},
  series       = {{Clinica Chimica Acta}},
  title        = {{An international study on activated partial thromboplastin time prolongation. Part 1 : Analytical results}},
  url          = {{http://dx.doi.org/10.1016/j.cca.2022.08.024}},
  doi          = {{10.1016/j.cca.2022.08.024}},
  volume       = {{535}},
  year         = {{2022}},
}